Lenalidomid induced interstitial pneumonitis

S. Györik, J. Feichenfeldt, F. Quadri, E. Lerch (Bellinzona, Switzerland)

Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Session: Interstitial lung disease in systemic and vascular disorders
Session type: Thematic Poster Session
Number: 1900
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Györik, J. Feichenfeldt, F. Quadri, E. Lerch (Bellinzona, Switzerland). Lenalidomid induced interstitial pneumonitis. Eur Respir J 2008; 32: Suppl. 52, 1900

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Chronic hypersensitivity pneumonitis and its differential diagnosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=189
Year: 2007

Ciprofloxacin-induced acute interstitial pneumonitis
Source: Eur Respir J 2004; 23: 172-174
Year: 2004



Usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Pembrolizumab-induced pneumonitis
Source: ERJ Open Res, 3 (2) 00081-2016; 10.1183/23120541.00081-2016
Year: 2017



Idelalisib-related pneumonitis
Source: Eur Respir J 2016; 47: 1280-1283
Year: 2016


Bosutinib-related pneumonitis
Source: Eur Respir J, 50 (3) 1700930; 10.1183/13993003.00930-2017
Year: 2017



Distinguishing fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
Source: International Congress 2019 – Lungs in the fog
Year: 2019


Interstitial pneumonia vs. hypersensitivity pneumonitis with autoimmune features
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017

Evaluation of interstitial inflammatory cell in idiopathic interstitial pneumonias
Source: Eur Respir J 2006; 28: Suppl. 50, 99s
Year: 2006

Near-fatal non-specific interstitial pneumonitis in a construction worker
Source: Annual Congress 2013 –Environment respiratory diseases Grand Round: an interactive session
Year: 2013

Levels of cytokines and chemokines in BAL fluid in patients with idiopathic interstitial pneumonitis and collagen vascular disease associated interstitial pneumonitis
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011

Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
Source: Eur Respir J 2005; 25: 528-533
Year: 2005



Nonspecific interstitial pneumonitis as a cause of dyspnea
Source: Eur Respir J 2004; 24: Suppl. 48, 716s
Year: 2004

Cyclosporine A in the treatment of idiopathic pulmonary fibrosis/usual interstitial pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 62s
Year: 2002

Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
Source: Eur Respir J, 54 (1) 1900531; 10.1183/13993003.00531-2019
Year: 2019



Chronic interstitial pneumonitis in end-stage sarcoidosis
Source: Eur Respir J 2010; 35: 695-697
Year: 2010


Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP)
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006

Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 18: 43S-55S
Year: 2001



Cyclophosphamide in steroid-refractory hypersensitivity pneumonitis and non-classifiable interstitial lung disease
Source: International Congress 2017 – Novel and old entities
Year: 2017

The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008